Purpose: Current and future treatment modalities for Clostridium difficile-associated disease (CDAD) are reviewed. Conclusion: CDAD is a major concern for health care systems and clinicians.

Bezlotoxumab, an IgG1 monoclonal antibody targeting C. difficile toxin B, is recommended for high-risk patients to prevent further recurrences. While the addition of bezlotoxumab has shown benefit in ...

The ability to perceive the bitter taste is thought to have evolved as a protective mechanism, signaling the presence of toxins in foods. When we bite bitter compounds, TAS2Rs respond by ...

One of these, mainly needed for Rompopolo gear – as well as Rathian and Gypceros armor sets – is Toxin Sacs. Toxin Sacs are the organs of the monster who’s dropped them, often packed with ...